Cargando…
Serum S100 calcium-binding protein A4 as a novel predictive marker of acute exacerbation of interstitial pneumonia after surgery for lung cancer
BACKGROUND: Acute exacerbation (AE) of interstitial pneumonia (IP) is the most fatal complication after lung resection for lung cancer. To improve the prognosis of lung cancer with IP, the risk factors of AE of IP after lung resection should be assessed. S100 calcium-binding protein A4 (S100A4) is a...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8173829/ https://www.ncbi.nlm.nih.gov/pubmed/34078355 http://dx.doi.org/10.1186/s12890-021-01554-y |
_version_ | 1783702786494431232 |
---|---|
author | Kagimoto, Atsushi Tsutani, Yasuhiro Kushitani, Kei Kambara, Takahiro Mimae, Takahiro Miyata, Yoshihiro Takeshima, Yukio Okada, Morihito |
author_facet | Kagimoto, Atsushi Tsutani, Yasuhiro Kushitani, Kei Kambara, Takahiro Mimae, Takahiro Miyata, Yoshihiro Takeshima, Yukio Okada, Morihito |
author_sort | Kagimoto, Atsushi |
collection | PubMed |
description | BACKGROUND: Acute exacerbation (AE) of interstitial pneumonia (IP) is the most fatal complication after lung resection for lung cancer. To improve the prognosis of lung cancer with IP, the risk factors of AE of IP after lung resection should be assessed. S100 calcium-binding protein A4 (S100A4) is a member of the S100 family of proteins and is a known marker of tissue fibrosis. We examined the usefulness of S100A4 in predicting AE of IP after lung resection for lung cancer. METHODS: This study included 162 patients with IP findings on preoperative high-resolution computed tomography scan who underwent curative-intent lung resection for primary lung cancer between April 2007 and March 2019. Serum samples were collected preoperatively. Resected lung tissue from 76 patients exhibited usual IP (UIP) pattern in resected lung were performed immunohistochemistry (IHC). Relationship between S100A4 and the incidence of AE of IP and short-term mortality was analyzed. RESULTS: The receiver operating characteristic area under the curve for serum S100A4 to predict postoperative AE of IP was 0.871 (95% confidence interval [CI], 0.799–0.943; P < 0.001), with a sensitivity of 93.8% and a specificity of 75.3% at the cutoff value of 17.13 ng/mL. Multivariable analysis revealed that a high serum S100A4 level (> 17.13 ng/mL) was a significant risk factor for AE of IP (odds ratio, 42.28; 95% CI, 3.98–449.29; P = 0.002). A 1-year overall survival (OS) was significantly shorter in patients with high serum levels of S100A4 (75.3%) than in those with low serum levels (92.3%; P = 0.003). IHC staining revealed that fibroblasts, lymphocytes, and macrophages expressed S100A4 in the UIP area, and the stroma and fibrosis in the primary tumor expressed S100A4, whereas tumor cells did not. CONCLUSIONS: Serum S100A4 had a high predictive value for postoperative AE of IP and short-term mortality after lung resection. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12890-021-01554-y. |
format | Online Article Text |
id | pubmed-8173829 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-81738292021-06-03 Serum S100 calcium-binding protein A4 as a novel predictive marker of acute exacerbation of interstitial pneumonia after surgery for lung cancer Kagimoto, Atsushi Tsutani, Yasuhiro Kushitani, Kei Kambara, Takahiro Mimae, Takahiro Miyata, Yoshihiro Takeshima, Yukio Okada, Morihito BMC Pulm Med Research BACKGROUND: Acute exacerbation (AE) of interstitial pneumonia (IP) is the most fatal complication after lung resection for lung cancer. To improve the prognosis of lung cancer with IP, the risk factors of AE of IP after lung resection should be assessed. S100 calcium-binding protein A4 (S100A4) is a member of the S100 family of proteins and is a known marker of tissue fibrosis. We examined the usefulness of S100A4 in predicting AE of IP after lung resection for lung cancer. METHODS: This study included 162 patients with IP findings on preoperative high-resolution computed tomography scan who underwent curative-intent lung resection for primary lung cancer between April 2007 and March 2019. Serum samples were collected preoperatively. Resected lung tissue from 76 patients exhibited usual IP (UIP) pattern in resected lung were performed immunohistochemistry (IHC). Relationship between S100A4 and the incidence of AE of IP and short-term mortality was analyzed. RESULTS: The receiver operating characteristic area under the curve for serum S100A4 to predict postoperative AE of IP was 0.871 (95% confidence interval [CI], 0.799–0.943; P < 0.001), with a sensitivity of 93.8% and a specificity of 75.3% at the cutoff value of 17.13 ng/mL. Multivariable analysis revealed that a high serum S100A4 level (> 17.13 ng/mL) was a significant risk factor for AE of IP (odds ratio, 42.28; 95% CI, 3.98–449.29; P = 0.002). A 1-year overall survival (OS) was significantly shorter in patients with high serum levels of S100A4 (75.3%) than in those with low serum levels (92.3%; P = 0.003). IHC staining revealed that fibroblasts, lymphocytes, and macrophages expressed S100A4 in the UIP area, and the stroma and fibrosis in the primary tumor expressed S100A4, whereas tumor cells did not. CONCLUSIONS: Serum S100A4 had a high predictive value for postoperative AE of IP and short-term mortality after lung resection. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12890-021-01554-y. BioMed Central 2021-06-02 /pmc/articles/PMC8173829/ /pubmed/34078355 http://dx.doi.org/10.1186/s12890-021-01554-y Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Kagimoto, Atsushi Tsutani, Yasuhiro Kushitani, Kei Kambara, Takahiro Mimae, Takahiro Miyata, Yoshihiro Takeshima, Yukio Okada, Morihito Serum S100 calcium-binding protein A4 as a novel predictive marker of acute exacerbation of interstitial pneumonia after surgery for lung cancer |
title | Serum S100 calcium-binding protein A4 as a novel predictive marker of acute exacerbation of interstitial pneumonia after surgery for lung cancer |
title_full | Serum S100 calcium-binding protein A4 as a novel predictive marker of acute exacerbation of interstitial pneumonia after surgery for lung cancer |
title_fullStr | Serum S100 calcium-binding protein A4 as a novel predictive marker of acute exacerbation of interstitial pneumonia after surgery for lung cancer |
title_full_unstemmed | Serum S100 calcium-binding protein A4 as a novel predictive marker of acute exacerbation of interstitial pneumonia after surgery for lung cancer |
title_short | Serum S100 calcium-binding protein A4 as a novel predictive marker of acute exacerbation of interstitial pneumonia after surgery for lung cancer |
title_sort | serum s100 calcium-binding protein a4 as a novel predictive marker of acute exacerbation of interstitial pneumonia after surgery for lung cancer |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8173829/ https://www.ncbi.nlm.nih.gov/pubmed/34078355 http://dx.doi.org/10.1186/s12890-021-01554-y |
work_keys_str_mv | AT kagimotoatsushi serums100calciumbindingproteina4asanovelpredictivemarkerofacuteexacerbationofinterstitialpneumoniaaftersurgeryforlungcancer AT tsutaniyasuhiro serums100calciumbindingproteina4asanovelpredictivemarkerofacuteexacerbationofinterstitialpneumoniaaftersurgeryforlungcancer AT kushitanikei serums100calciumbindingproteina4asanovelpredictivemarkerofacuteexacerbationofinterstitialpneumoniaaftersurgeryforlungcancer AT kambaratakahiro serums100calciumbindingproteina4asanovelpredictivemarkerofacuteexacerbationofinterstitialpneumoniaaftersurgeryforlungcancer AT mimaetakahiro serums100calciumbindingproteina4asanovelpredictivemarkerofacuteexacerbationofinterstitialpneumoniaaftersurgeryforlungcancer AT miyatayoshihiro serums100calciumbindingproteina4asanovelpredictivemarkerofacuteexacerbationofinterstitialpneumoniaaftersurgeryforlungcancer AT takeshimayukio serums100calciumbindingproteina4asanovelpredictivemarkerofacuteexacerbationofinterstitialpneumoniaaftersurgeryforlungcancer AT okadamorihito serums100calciumbindingproteina4asanovelpredictivemarkerofacuteexacerbationofinterstitialpneumoniaaftersurgeryforlungcancer |